Trial of High-Dose Blood Thinners in I.C.U. Coronavirus Patients Is Halted
Giving anticoagulants to hospitalized Covid-19 patients is routine. But high doses may sometimes do more harm than good, a safety board finds.
Source: NYT Health - Category: Consumer Health News Authors: Donald G. McNeil Jr. Tags: Clinical Trials Coronavirus (2019-nCoV) Blood Clots National Institutes of Health Journal of the American College of Cardiology University of Pittsburgh Medical Center New York University your-feed-healthcare Source Type: news
More News: Cardiology | Clinical Trials | Coronavirus | COVID-19 | Health | Heart | National Institutes of Health (NIH) | New York University